Laboratoires Thea SA - Company Profile

Powered by

All the data and insights you need on Laboratoires Thea SA in one report.

$1,795 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Laboratoires Thea SA Strategy Report

  • Understand Laboratoires Thea SA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Laboratoires Thea SA: Overview

Select Item

Laboratoires Thea SA (Thea) is a pharmaceutical company that researches, develops, manufactures, and commercializes a wide variety of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, glaucoma, ocular and eyelid hygiene, eye surgery, and violations of the posterior segment. Its product portfolio includes eye drops, ophthalmic gels, sterile compresses, and micellar solutions. Thea markets these products under the brand names Blephagel, Blephasteam, Nutrof, ABAK, Blephasol, and Blephaclean. The company markets products through sales organizations and distributors. Thea is headquartered in Clermont Ferrand, Auvergne, France.

 Gain a 360-degree view of Laboratoires Thea SA and make more informed decisions for your business Gain a 360-degree view of Laboratoires Thea SA and make more informed decisions for your business Find out more
Headquarters France
Address 12 Street Louis-Bleriot, Zone Industrielle du Brezet, Clermont Ferrand, Auvergne, 63100
Website www.laboratoires-thea.com
Telephone 33 473 981436
Industry Pharmaceuticals and Healthcare
Revenue (2022) $909.6M
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Laboratoires Thea SA premium industry data and analytics

60+

Marketed Drugs

Understand Laboratoires Thea SA’s commercialized product portfolio to stay one step ahead of the market.

60+

Clinical Trials

Determine Laboratoires Thea SA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Laboratoires Thea SA’s relevant decision makers and contact details.

20+

Catalyst Calendar

Proactively evaluate Laboratoires Thea SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

14+

Pipeline Drugs

Identify which of Laboratoires Thea SA’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Investigators

Review investigator profiles and find information on trial contacts across Laboratoires Thea SA, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Laboratoires Thea SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
- Blephagel
Ophthalmic Ointments: Blephasteam
Antiseptics and Antibiotics Nutrof
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Laboratoires Thea SA portfolio and identify potential areas for collaboration Understand Laboratoires Thea SA portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Asset Purchase In December, the company acquired late-stage ophthalmic assets, sepofarsen and ultevursen, from ProQR Therapeutics N.V.
2023 Others In September, the company terminated the acquisition of Sepofarsen and Ultevursen Ophthalmic assets from ProQR Therapeutics.
2023 Contracts/Agreements In September, Thea Open Innovation signed a partnership agreement with Link Biologics to develop Link_TSG6 for dry eyes.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Laboratoires Thea SA Alcon Inc NicOx SA Horus Pharma SAS Ziemer Ophthalmic Systems AG
Headquarters France Switzerland France France Switzerland
City Clermont Ferrand Fribourg Valbonne Nice Bern
State/Province Auvergne Freiburg Provence - Alpes- Cote d'Azur Provence - Alpes- Cote d'Azur Bern
No. of Employees - 25,315 11 - -
Entity Type Private Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Serge Resnikoff, M.D., Ph.D. Chairman Executive Board - -
Serge Resnikoff Director Non Executive Board - -
Jean-Frederic Chibret Director Non Executive Board - -
Henri Chibret Director Non Executive Board - -
Didier Renault Director Non Executive Board - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Laboratoires Thea SA key executives to enhance your sales strategy Gain insight into Laboratoires Thea SA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward